Actively Recruiting

Phase 3
Age: 18Years - 100Years
All Genders
NCT07246187

Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department

Led by Mercy Bon Secours Saint Vincent Medical Center · Updated on 2025-11-24

114

Participants Needed

1

Research Sites

51 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannabinoid hyperemesis using a 10-point visual analog scale with intervals of 0.5.

CONDITIONS

Official Title

Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Use cannabis by inhalation nearly every day for at least 6 months
  • Have a previous diagnosis of cannabinoid hyperemesis, OR
  • Have had 3 or more vomiting episodes in a cyclic pattern separated by over 1 month during the last 2 years, OR
  • The doctor suspects cannabinoid hyperemesis as the main or equally likely diagnosis
Not Eligible

You will not qualify if you...

  • Younger than 18 years old
  • Weigh less than 50 kg
  • Are pregnant or breastfeeding
  • Use benzodiazepines daily
  • Have a prolonged QTc interval on ECG
  • Have known allergy or intolerance to haloperidol or olanzapine
  • Take drugs that cannot be combined with haloperidol or olanzapine
  • Have Parkinson's Disease
  • Are already taking haloperidol, olanzapine, or other antipsychotics

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mercy Saint Vincent Medical Center

Toledo, Ohio, United States, 43608

Actively Recruiting

Loading map...

Research Team

J

Joseph Jabour, DO FACEP

CONTACT

A

Amanda Gutek

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here